Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Altitude Acquisition (ALTU) has provided an announcement.
Altitude Acquisition Corp. has mutually terminated its business combination agreement with Picard Medical, Inc. without any termination fees and has instead entered a new agreement to merge with Vesicor Therapeutics, Inc., an early-stage biopharmaceutical company. Upon completion of the merger, subject to stockholder and regulatory approvals, Vesicor will become a wholly-owned subsidiary of Altitude, which will be renamed Vesicor Therapeutics, Inc. The merger’s finalization is contingent upon customary closing conditions, including the SEC’s approval of a Registration Statement. This strategic pivot aims to capitalize on Vesicor’s potential in microvesicle-based therapeutics.
For an in-depth examination of ALTU stock, go to TipRanks’ Stock Analysis page.
